The role of PET/CT in detection of gastric cancer recurrence

The role of PET/CT in detection of gastric cancer recurrence

<p>Abstract</p> <p>Background</p> <p>In the course of surveillance of gastric cancer recurrence after curative resection, contrast CT scan is used in general. However, new findings from CT scan are not always confirmatory for the recurrence. In this case, we usually use...

Full description

Bibliographic Details
Main Authors:	Kang Won, Kim Dong-Wan, Lee Se-Hoon, Oh Do-Youn, Kim Yu, Sim Sung, Im Seock-Ah, Kim Tae-You, Kim Woo, Heo Dae, Bang Yung-Jue
Format:	Article
Language:	English
Published:	BMC 2009-03-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/9/73

Similar Items

Diagnostic performance of contrast enhanced CT and <sup>18</sup>F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
by: Im Seock-Ah, et al.
Published: (2011-05-01)

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
by: Oh Do-Youn, et al.
Published: (2011-05-01)

Diagnostic performance of F-18 FDG PET or PET/CT for detection of recurrent gastric cancer: a systematic review and meta-analysis
by: Chang In Choi, et al.
Published: (2023-11-01)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
by: Kim Dong-Wan, et al.
Published: (2007-04-01)

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
by: Kim Dong-Wan, et al.
Published: (2007-11-01)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
by: Younak Choi, et al.
Published: (2015-01-01)

The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma
by: Song Kyo, et al.
Published: (2010-10-01)

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity.
by: Younak Choi, et al.
Published: (2016-01-01)

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
by: Kim Tae-You, et al.
Published: (2009-09-01)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
by: Han Wonshik, et al.
Published: (2008-10-01)

Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
by: Hai-Jeon Yoon, et al.
Published: (2018-01-01)

18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
by: Hyun Jeong Kim, et al.
Published: (2022-12-01)

Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.
by: Ji-In Bang, et al.
Published: (2018-01-01)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
by: Kim Tae-You, et al.
Published: (2010-10-01)

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
by: Jin Won Kim, et al.
Published: (2020-02-01)

Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure
by: Dong-Yun Kim, et al.
Published: (2023-06-01)

Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance
by: Koung Jin Suh, et al.
Published: (2019-07-01)

FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
by: Jonathan D. West MD, et al.
Published: (2021-11-01)

Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and Recurrence Risks in Patients with Advanced Gastric Cancers
by: Hyein Ahn, et al.
Published: (2022-08-01)

Added Value of the Sliding Sign on Right Down Decubitus CT for Determining Adjacent Organ Invasion in Patients with Advanced Gastric Cancer
by: Kyutae Jeon, et al.
Published: (2022-11-01)

eradication reduces risk for recurrence of gastric hyperplastic polyp after endoscopic resection
by: Young Sin Cho, et al.
Published: (2023-03-01)

CT, MRI, and FDG PET/CT Findings of Sinonasal Sarcoma: Differentiation from Squamous Cell Carcinoma
by: Jin Ho Kim, et al.
Published: (2016-07-01)

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.
by: Hye Rim Ha, et al.
Published: (2016-01-01)

Tracing of the Bile-chemotactic migration of juvenile Clonorchis sinensis in rabbits by PET-CT.
by: Tae Im Kim, et al.
Published: (2011-12-01)

Solitary Pulmonary Capillary Hemangioma: CT and PET-CT Features with Clinicopathologic Correlation
by: Min Ju Kim, et al.
Published: (2022-10-01)

Choline PET/CT in recurrent prostate cancer
by: Beatrice Detti, et al.
Published: (2023-03-01)

A Case of Recurrence-Mimicking Charcoal Granuloma in a Breast Cancer Patient: Ultrasound, CT, PET/CT and Breast-Specific Gamma Imaging Findings
by: Dae Woong Park, et al.
Published: (2016-07-01)

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
by: Dae-Won Lee, et al.
Published: (2018-03-01)

18F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value
by: Jin Suk Kim, et al.
Published: (2014-05-01)

Prognostic value of the metabolic score obtained via [18F]FDG PET/CT and a new prognostic staging system for gastric cancer
by: Sung Hoon Kim, et al.
Published: (2022-11-01)

Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer
by: Young-Woo Kim, et al.
Published: (2019-08-01)

Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
by: Sung Hoon Kim, et al.
Published: (2019-03-01)

Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma
by: Lim CH, et al.
Published: (2021-09-01)

FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma
by: Joon-Hyung Jo, et al.
Published: (2022-03-01)

Usefulness of PET-CT scan in recurrent thyroid cancer
by: Gianlorenzo Dionigi, et al.
Published: (2020-09-01)

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
by: Sehhoon Park, et al.
Published: (2018-01-01)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
by: Ja Kyung Yoon, et al.
Published: (2022-10-01)

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
by: Yong-Jin Park, et al.
Published: (2021-04-01)

Predicting the Recurrence of Gastric Cancer Using the Textural Features of Perigastric Adipose Tissue on [<sup>18</sup>F]FDG PET/CT
by: Hyein Ahn, et al.
Published: (2022-10-01)

Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer
by: Kim Sung, et al.
Published: (2009-08-01)